[HTML][HTML] Long non-coding RNAs in anti-cancer drug resistance
Q Chen, C Wei, Z Wang, M Sun - Oncotarget, 2017 - ncbi.nlm.nih.gov
Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly
responsible for the failure of clinical treatment. The mechanism of drug resistance is …
responsible for the failure of clinical treatment. The mechanism of drug resistance is …
[HTML][HTML] Recent progress in characterizing long noncoding RNAs in cancer drug resistance
Drug resistance is an important cause of failure in cancer chemotherapies. A large number
of long noncoding RNAs (lncRNAs) have been found to be related to drug resistance in …
of long noncoding RNAs (lncRNAs) have been found to be related to drug resistance in …
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
W Jiang, J Xia, S Xie, R Zou, S Pan, Z Wang… - Drug Resistance …, 2020 - Elsevier
Chemoresistance including intrinsic and acquired anticancer drug resistance continues to
be a primary hindrance towards curative cancer treatment. Therefore, deciphering the …
be a primary hindrance towards curative cancer treatment. Therefore, deciphering the …
Long non-coding RNAs in cancer drug resistance development
M Majidinia, B Yousefi - DNA repair, 2016 - Elsevier
The presence or emergence of chemoresistance in tumor cells is a major burden in cancer
therapy. While drug resistance is a multifactorial phenomenon arising from altered …
therapy. While drug resistance is a multifactorial phenomenon arising from altered …
The functional role of long noncoding RNA in resistance to anticancer treatment
Y Qu, HY Tan, YT Chan, H Jiang… - … advances in medical …, 2020 - journals.sagepub.com
Chemotherapy is one of the fundamental methods of cancer treatment. However, drug
resistance remains the main cause of clinical treatment failure. We comprehensively review …
resistance remains the main cause of clinical treatment failure. We comprehensively review …
LncRNA as a multifunctional regulator in cancer multi-drug resistance
J He, S Zhu, X Liang, Q Zhang, X Luo, C Liu… - Molecular Biology …, 2021 - Springer
Background Malignant tumors have become the most dangerous disease in recent years.
Chemotherapy is the most effective treatment for this disease; however, the problem of drug …
Chemotherapy is the most effective treatment for this disease; however, the problem of drug …
Long non-coding RNA: a recently accentuated molecule in chemoresistance in cancer
Y Peng, D Tang, M Zhao, H Kajiyama… - Cancer and Metastasis …, 2020 - Springer
Chemotherapy is one of the important and effective options for cancer treatment in the past
decades. Although the response rate of initial chemotherapy is considerably high in certain …
decades. Although the response rate of initial chemotherapy is considerably high in certain …
Long non-coding RNAs regulate drug resistance in cancer
Chemoresistance, whether intrinsic or acquired, is a major obstacle in the treatment of
cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various …
cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various …
Long non-coding RNA mediated drug resistance in breast cancer
Breast cancer is one of the most prevalent cancers in women and a leading cause of
mortality. As per the GLOBCAN report of 2021, breast cancer has surpassed lung cancer …
mortality. As per the GLOBCAN report of 2021, breast cancer has surpassed lung cancer …
Role of long non-coding RNA in tumor drug resistance
H Deng, J Zhang, JJ Shi, ZD Guo, CR He, L Ding… - Tumor Biology, 2016 - Springer
Chemotherapy has been extensively used in tumor treatment, including either systemic or
local treatment. Miserably, in many kinds of cancers, chemotherapy is gradually insensitive …
local treatment. Miserably, in many kinds of cancers, chemotherapy is gradually insensitive …